Hydrodynamic tail vein injection

JW Jingxiao Wang
MD Mingjie Dong
ZX Zhong Xu
XS Xinhua Song
SZ Shanshan Zhang
YQ Yu Qiao
LC Li Che
JG John Gordan
KH Kaiwen Hu
YL Yan Liu
DC Diego F. Calvisi
XC Xin Chen
request Request a Protocol
ask Ask a question
Favorite

We employed hydrodynamic injection as previously described in detail [47]. The dosage of pT3-EF1α-HA-myr-AKT (AKT) and pT3-EF1α-YapS127A (Yap) plasmids was 20 and 30 μg, respectively. To suppress the canonical Notch signaling, we applied 60 μg pT3-EF1α-dnRBPJ or 60 μg pT3-EF1α together with AKT and Yap plasmids in FVB/N mice. In transgenic models, we injected 60 μg pCMV-Cre or 60 μg empty pCMV vector together with AKT/Yap. Mice were housed, fed, and monitored according to protocols approved by the Committee for Animal Research at the University of California San Francisco (San Francisco, CA).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A